Results 161 to 170 of about 836,777 (260)

Mapping Mutations and Signaling Network Interactions to Guide Precision Therapy in Gallbladder Cancer

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Gallbladder cancer (GBC) is a biologically complex malignancy arising from the epithelial lining of the gallbladder, with adenocarcinoma constituting the major histological subtype. Early detection is challenging because of vague clinical manifestations and the organ's deep‐seated anatomical location, resulting in diagnosis at ...
Nisha Manav, Akanksha Kashyap, Lakshay Malhotra, Chethan Rajegowda, Chandra Prakash Prasad   +4 more
wiley   +1 more source

The Genomic Patterns of Well-Differentiated Pancreatic Neuroendocrine Tumors (NETs) Identify Sub-Sets for Rational Therapeutic Targeting. [PDF]

Int J Mol Sci
Voutsadakis IA.
europepmc   +1 more source

Case Report: Pancreatic Paraganglioma Mimicking a Well‐Differentiated Neuroendocrine Tumor: The Importance of Cytokeratin Immunohistochemistry

Diagnostic Cytopathology, Volume 54, Issue 10, Page E240-E243, October 2026.
ABSTRACT Paragangliomas (PGLs) are uncommon neuroendocrine tumors most commonly found in the head and neck that originate from neural crest cells. Primary pancreatic paraganglioma is exceedingly rare and has largely been described in case reports and small case series. We present the case of a 79‐year‐old woman with an incidental pancreatic head lesion
Tanner Storozuk, Marc Vecchio
wiley   +1 more source

Functional Status and Postoperative Outcomes After Left Pancreatectomy for Pancreatic Neuroendocrine Tumors: An Exploratory Analysis from the Prospective SPANDISPAN Study. [PDF]

J Clin Med
Ramia JM, Hernández-Roca B, Rubio-García JJ, Aparicio-López D, Busquets J, Secanella L, Peláez N, Alkorta M, de Ariño-Hervás I, Del Mar Achalandabaso M, Toledo E, Rotellar F, Martí-Cruchaga P, Ángel Gómez-Bravo M, Suárez G, Garcés-Albir M, Sabater L, García G, Javier Alcalá F, Asensio E, Pacheco D, Cugat E, Espín F, Galófre M, Sánchez B, Santoyo J, Calvo J, Loinaz C, García-Domingo MI, Sánchez-Cabús S, Martín B, Blanco-Fernández G, Jaén-Torrejimeno I, Domingo C, Payá C, González C, Ruiz S, López-Andújar R, Ballester C, Belén Vico A, Zambudio N, Estévez S, Nogueira-Sixto M, Ignacio Miota J, Conde B, Ángel Suárez M, Roldán de la Rúa J, Blanco A, González M, Elena González P, Reyes B, López-Ben S, Tió B, Mínguez J, Lasa I, Miyar A, Solar L, Burdío F, Ielpo B, Carabias A, Sanz-Muñoz MP, Escartín A, Vela F, Marqués E, Pérez A, Palomares G, Calvo A, Tomás Castell J, Jesús Castro M, Manzanares MDC, Artigues E, Luis Blas J, Díez L, Calero A, Quiñones JE, Rodríguez M, Serradilla-Martín M, Alcázar-López CF, Villodre C.   +78 more
europepmc   +1 more source

What Is Your Diagnosis? Splenic Mass in an African Pygmy Hedgehog

Veterinary Clinical Pathology, EarlyView.
Gabriela Hartmann, Milena Carolina Paz, Paola Sônego, Ana Carolina Contri Natal, Lívia Surita, Marcele Bettim Bandinelli, Luciana Sonne   +6 more
wiley   +1 more source

Predominance of In‐Field Recurrence After Radiotherapy for Sinonasal Cancer: A Single‐Center Retrospective Study

Head &Neck, Volume 48, Issue 10, Page 2704-2712, October 2026.
ABSTRACT Background Sinonasal malignancies (SNM) are rare, heterogeneous tumors with poor prognosis. There is an unmet need to improve treatment outcomes. Despite advances in imaging and molecular classification, optimal curative radiotherapy (RT) strategies remain undefined.
M. de Ridder, L. J. van de Velde, T. de Bie, R. van Noortwijk, C. P. J. Raaijmakers, E. H. Voormolen, W. W. Braunius, R. de Bree, G. E. Breimer, L. A. Devriese, E. J. Smid, J. A. Rijken   +11 more
wiley   +1 more source

Pancreatic Neuroendocrine Tumors: From Benchside to Surgical Treatment. [PDF]

Medicina (Kaunas)
Conzo G, Mongardini FM, Paolicelli M, Klain M, Bellastella G, Conzo A, Bo Z, Lanza E, Piscopo L, Patrone R.   +9 more
europepmc   +1 more source

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change

International Journal of Cancer, Volume 159, Issue 7, Page 1588-1601, 1 October 2026.
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley, Liesbet J. Van Eycken, Meredith E. Giuliani, Brian A. Rous, Shao Hui Huang, Hisao Asamura, Mary K. Gospodarowicz, Anne W. Lee, Brian O'Sullivan   +8 more
wiley   +1 more source

Distinct Malignant Cell States and Myeloid Glutamate Signaling Associated with Aggressive Pancreatic Neuroendocrine Tumors. [PDF]

Clin Cancer Res
Arbesfeld-Qiu JM, Cho JW, Nguyen PTT, Lester NA, Su J, Shiau C, Guo JA, Hoffman H, Caldwell NJ, Muratani S, Galvan M, Proctor JE, Ely ZA, Wang S, Ganci M, Dries R, Hong T, Wo J, Boland G, Fernandez-Del Castillo C, Ferrone CR, Heaphy CM, Zhang ML, Mino-Kenudson M, Hemberg M, Hwang WL.   +25 more
europepmc   +1 more source

Targeting the DNA Damage Response in Cancer

MedComm, Volume 7, Issue 10, October 2026.
Targeting the DNA damage response (DDR) reshapes both tumor vulnerability and antitumor immunity. DNA lesions and DDR inhibitors can promote cytosolic nucleic‐acid sensing, antigen presentation, and immune activation, but can also induce adaptive immune escape.
Yihuan Qiao, Boyu Kang, Jian Zhang, Rui Zhang, Jipeng Li   +4 more
wiley   +1 more source